Based on the provided abstracts, there is insufficient information to accurately describe the function of the DR1 gene (down-regulator of transcription 1). The abstracts primarily discuss HLA-DR1, which is a different molecule - an MHC class II antigen involved in immune responses and disease susceptibility 1234. Only one abstract directly addresses the transcriptional regulator DR1, showing that it forms a heterodimeric repressor complex with DRAP1 that inhibits transcription of CASTOR1, leading to increased mTOR activity and promoting triple-negative breast cancer progression 5. This study demonstrates that DR1 and DRAP1 form a positive feedback loop, where DR1 directly promotes DRAP1 transcription while DRAP1 enhances DR1 stability by recruiting the deubiquitinase USP7 5. The DR1/DRAP1 complex appears to function as a transcriptional corepressor that dysregulates mTOR signaling in cancer contexts 5. However, the limited data prevents comprehensive characterization of DR1's primary cellular functions, broader mechanisms of action, or clinical significance beyond this specific cancer context.